Our pre-settlement funding for defective drug cases in South Dakota isn’t a loan. We offer non-recourse cash advances on your settlement. Bills don‘t wait—and neither should you to get the money you need when you need it.
With Pegasus Legal Capital’s South Dakota personal injury pre-settlement funding, you’re getting a risk-free cash advance based on your case’s expected value, not a debt you must repay regardless of outcome. When you have a case that can last years, this can make a huge difference in your outcome.
What Non-Recourse Funding Actually Means in Mass Tort Cases
Non-recourse means we assume all risk if you lose your case. If your defective drug case receives no settlement, you owe nothing. If bellwether trials go badly and the pharmaceutical company wins, you keep the funding with zero repayment obligation. If you’re excluded from the settlement class, you have no debt.
Traditional loans work the opposite way. Banks lend money secured by your obligation to repay, regardless of circumstances. Your case wins or loses? You still owe the bank. The pharmaceutical company declares bankruptcy? Your loan debt remains. Traditional financing transfers risk to you.
Defective Drug Cases are Long
South Dakota residents with defective drug cases need this protection because pharmaceutical litigation outcomes remain uncertain for years.
Your individual case’s outcome depends partly on bellwether trial results you can’t control. Settlement tier placement depends on evolving medical evidence. Non-recourse funding protects you through all these uncertainties.
Here’s what you never owe with non-recourse South Dakota pre-settlement funding:
- Nothing if bellwether trials result in defense verdicts
- Nothing if the MDL judge dismisses cases on summary judgment
- Nothing if you’re excluded from the settlement class due to timing or eligibility
- Nothing if the pharmaceutical company successfully appeals and wins
- Nothing if your case settles for less than the funding amount advanced
Schedule your free consultation today 855-386-3968
Pre-Settlement Funding vs. Other Financing for Extended Litigation
Let’s compare pre-settlement funding to bank loans for someone facing 3-5 years of defective drug litigation. A $30,000 personal loan at 12% APR costs $334 monthly. Over five years, you pay $50,040 total. You owe this regardless of your case outcome.
Credit cards create worse situations. That same $30,000 on cards averaging 24% interest costs $750+ monthly. Paying bills on a credit card creates an incredible amount of interest, and many victims cannot work to pay back the lender.
Our South Dakota defective drugs pre-settlement funding operates differently. You receive $30,000. No monthly payments. No credit checks. No employment verification.
You repay us from your settlement proceeds what you borrowed, plus a lending fee. Your case loses or settles for a minimal amount? You owe nothing.
Special Considerations for MDL Plaintiffs
Multi-District Litigation (MDL) creates uncertainties that make non-recourse protection especially valuable. Your individual case gets consolidated with thousands of others. Settlement negotiations involve collective bargaining, where individual plaintiffs have limited input.
MDL consolidation means your case timeline extends beyond your control. The judge sets schedules based on the entire litigation’s needs. Bellwether trials, which create a baseline for compensation discussions, may not include anyone similar to your situation. Settlement negotiations happen in groups, not individually.
You can’t predict whether bellwether plaintiffs will win. You can’t control settlement tier definitions. You can’t accelerate your timeline. Non-recourse funding protects you throughout. If the collective litigation fails, you’re not personally liable for funding received.
Click to contact us today
About Pegasus Legal Capital
Pegasus Legal Capital has provided over $500 million in non-recourse pre-settlement funding to more than 15,000 clients since 2008. Our technology analyzes case strength, bellwether results, and settlement structures to determine appropriate funding amounts.
We’re direct lenders serving South Dakota residents in federal MDL proceedings and individual pharmaceutical litigation. As American Legal Finance Association members, we follow industry standards for transparent practices. We provide funding from $500 to $6,000,000 based on expected case value, fully accepting the risk that cases may not succeed.
Our non–recourse structure protects South Dakota plaintiffs through every litigation uncertainty. We fund cases involving prescription medications, over-the-counter drugs, medical devices, and pharmaceutical products.
Your credit score doesn’t affect eligibility. Your employment status doesn’t matter. Your existing debt doesn’t disqualify you.
Your pre-settlement funding consultation is free — contact us today!
Apply for Pre-Settlement Funding for South Dakota Defective Drugs Cases
Three to five years of litigation creates enormous financial pressure. Pharmaceutical companies exploit this through delay tactics and inadequate early settlement offers. They’re betting you can’t afford to wait. Traditional loans worsen this pressure by adding monthly payment obligations and personal debt risk.
South Dakota defective drugs pre-settlement funding removes this weapon. You receive immediate cash without creating personal debt. You can wait for bellwether trial results. Your attorney develops complete medical documentation. You reject lowball offers without fear.
Pegasus Legal Capital provides South Dakota residents with true non–recourse protection throughout defective drug litigation. Apply today for a free case evaluation. If you have a lawyer working on your case, your case may qualify for funding.
Your pre-settlement funding consultation is free — contact us today!